Log in to save to my catalogue

Corticosteroids for diabetic macular edema

Corticosteroids for diabetic macular edema

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_59e673d48bc745d5b581f01ec1a42d8c

Corticosteroids for diabetic macular edema

About this item

Full title

Corticosteroids for diabetic macular edema

Publisher

India: Wolters Kluwer - Medknow Publications

Journal title

Taiwan journal of ophthalmology, 2019-10, Vol.9 (4), p.233-242

Language

English

Formats

Publication information

Publisher

India: Wolters Kluwer - Medknow Publications

More information

Scope and Contents

Contents

Diabetic macular edema (DME) is a chronic condition with a multifactorial pathogenesis. Vascular endothelial growth factor (VEGF) and several inflammatory mediators are upregulated in eyes with DME. VEGF inhibitors and corticosteroids have all been used successfully in the management of DME. Currently available corticosteroids include triamcinolone...

Alternative Titles

Full title

Corticosteroids for diabetic macular edema

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_59e673d48bc745d5b581f01ec1a42d8c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_59e673d48bc745d5b581f01ec1a42d8c

Other Identifiers

ISSN

2211-5056

E-ISSN

2211-5072

DOI

10.4103/tjo.tjo_68_19

How to access this item